Central injection of botulinum neurotoxins: behavioural effects in mice

被引:26
作者
Luvisetto, S
Marinelli, S
Rossetto, O
Montecucco, C
Pavone, F
机构
[1] CNR, Ist Neurosci, Sez Psicobiol & Psicofarmacol, I-00137 Rome, Italy
[2] Univ Padua, Dipartimento Sci Biomed Sperimentali, Padua, Italy
来源
BEHAVIOURAL PHARMACOLOGY | 2004年 / 15卷 / 03期
关键词
botulinum; central nervous system; active avoidance; object recognition; locomotor activity; scopolamine; oxotremorine; mouse;
D O I
10.1097/01.fbp.0000129746.14753.1e
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Strains of Clostridium botulinum produce seven antigenically distinct botulinum neurotoxins (BoNTs) designated as serotypes A-G. All serotypes interfere with neural transmission by blocking the release of acetylcholine in cholinergic neurons. They cleave specific sites on proteins of the SNARE [soluble n-ethylmaleimide-sensitive factor (NSF) attachment protein receptor] complex, which play a key role in neuroexocytosis. This study assessed the behavioural effects due to central administration of BoNTs in mice. CD1 mice were injected intracerebroventricularly (icv) with sub-lethal doses of BoNT/A or /B and their behavioural responses in conditioning of active avoidance, object recognition test and pharmacologically induced locomotor activity were tested. Compared to control mice, BoNT-treated mice showed: (1) a reduced capacity to discriminate a novel object within a familiar environment; (2) an enhanced stimulant effect by scopolamine and a depressant effect by oxotremorine on locomotor activity. In contrast, central injection of BoNTs did not alter active avoidance acquisition. These results suggest an in vivo functional alteration due to the action of BoNTs directly administered into the central nervous system. The present data demonstrate that BoNTs may represent an analytical tool for studying the functional role of cholinergic neurons.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 49 条
[1]   Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine [J].
Ando, S ;
Kobayashi, S ;
Waki, H ;
Kon, K ;
Fukui, F ;
Tadenuma, T ;
Iwamoto, M ;
Takeda, Y ;
Izumiyama, N ;
Watanabe, K ;
Nakamura, H .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (03) :519-527
[2]  
BARTOLINI L, 1996, PHARM BIOCH BEHAV, V42, P277
[3]   Dopaminergic and cholinergic antagonism in a novel-object detection task with rats [J].
Besheer, J ;
Short, KR ;
Bevins, RA .
BEHAVIOURAL BRAIN RESEARCH, 2001, 126 (1-2) :211-217
[4]   SELECTIVE LOCATION OF ACCEPTORS FOR BOTULINUM NEUROTOXIN-A IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS [J].
BLACK, JD ;
DOLLY, JO .
NEUROSCIENCE, 1987, 23 (02) :767-779
[5]   THE ROLE OF THE MEDIAL PREFRONTAL CORTEX OF RATS IN SHORT-TERM-MEMORY FUNCTIONING - FURTHER SUPPORT FOR INVOLVEMENT OF CHOLINERGIC, RATHER THAN DOPAMINERGIC MECHANISMS [J].
BROERSEN, LM ;
HEINSBROEK, RPW ;
DEBRUIN, JPC ;
UYLINGS, HBM ;
OLIVIER, B .
BRAIN RESEARCH, 1995, 674 (02) :221-229
[6]   Functional repair of motor endplates after botulinum neurotoxin type A poisoning:: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals [J].
de Paiva, A ;
Meunier, FA ;
Molgó, J ;
Aoki, KR ;
Dolly, JO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3200-3205
[7]   MODULATORY FUNCTIONS OF NEUROTRANSMITTERS IN THE STRIATUM - ACH/DOPAMINE/NMDA INTERACTIONS [J].
DICHIARA, G ;
MORELLI, M ;
CONSOLO, S .
TRENDS IN NEUROSCIENCES, 1994, 17 (06) :228-233
[8]   THE BASAL FOREBRAIN CORTICAL CHOLINERGIC SYSTEM - INTERPRETING THE FUNCTIONAL CONSEQUENCES OF EXCITOTOXIC LESIONS [J].
DUNNETT, SB ;
EVERITT, BJ ;
ROBBINS, TW .
TRENDS IN NEUROSCIENCES, 1991, 14 (11) :494-501
[9]   A NEW ONE-TRIAL TEST FOR NEUROBIOLOGICAL STUDIES OF MEMORY IN RATS .1. BEHAVIORAL-DATA [J].
ENNACEUR, A ;
DELACOUR, J .
BEHAVIOURAL BRAIN RESEARCH, 1988, 31 (01) :47-59
[10]   EFFECTS OF PHYSOSTIGMINE AND SCOPOLAMINE ON RATS PERFORMANCES IN OBJECT-RECOGNITION AND RADIAL-MAZE TESTS [J].
ENNACEUR, A ;
MELIANI, K .
PSYCHOPHARMACOLOGY, 1992, 109 (03) :321-330